| __timestamp | Intra-Cellular Therapies, Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 12122000 |
| Thursday, January 1, 2015 | 87718074 | 13380000 |
| Friday, January 1, 2016 | 93831530 | 21221000 |
| Sunday, January 1, 2017 | 79419009 | 26887000 |
| Monday, January 1, 2018 | 132166913 | 27863000 |
| Tuesday, January 1, 2019 | 89124838 | 55908000 |
| Wednesday, January 1, 2020 | 65782137 | 59392000 |
| Friday, January 1, 2021 | 88845513 | 69012000 |
| Saturday, January 1, 2022 | 134715000 | 36082000 |
| Sunday, January 1, 2023 | 180142000 | 24537000 |
Unlocking the unknown
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Intra-Cellular Therapies, Inc. has consistently outpaced Ligand Pharmaceuticals Incorporated in R&D investment. From 2014 to 2023, Intra-Cellular Therapies increased its R&D spending by over 750%, peaking in 2023 with a remarkable 180 million dollars. In contrast, Ligand Pharmaceuticals saw a more modest growth, with its highest expenditure reaching approximately 69 million dollars in 2021. This trend highlights Intra-Cellular Therapies' aggressive pursuit of innovation, potentially positioning it as a leader in developing groundbreaking therapies. As the pharmaceutical landscape continues to shift, these investments could translate into significant advancements in treatment options, offering hope to patients worldwide.
Vertex Pharmaceuticals Incorporated vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development Investment: Zoetis Inc. vs Intra-Cellular Therapies, Inc.
Research and Development Expenses Breakdown: argenx SE vs Intra-Cellular Therapies, Inc.
Research and Development Investment: Genmab A/S vs Intra-Cellular Therapies, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Opthea Limited
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amicus Therapeutics, Inc.
Intra-Cellular Therapies, Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Insmed Incorporated and Ligand Pharmaceuticals Incorporated
Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated vs Xencor, Inc.: Strategic Focus on R&D Spending